BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Treatment
7 results:

  • 1. Predicting tumor response and outcome of second-look surgery with
    Aide N; Fauchille P; Coquan E; Ferron G; Combe P; Meunier J; Alexandre J; Berton D; Leary A; De Rauglaudre G; Bonichon N; Pujade Lauraine E; Joly F
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1998-2008. PubMed ID: 33221969
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Splicing factor proline- and glutamine-rich (sfpq) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
    Pellarin I; Dall'Acqua A; Gambelli A; Pellizzari I; D'Andrea S; Sonego M; Lorenzon I; Schiappacassi M; Belletti B; Baldassarre G
    Oncogene; 2020 May; 39(22):4390-4403. PubMed ID: 32332923
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Asymptomatic intrathyroidal pyriform sinus fistula mimicking thyroid cancer: A case report and literature review.
    Kim SC; Kim JH; Won JK; Chung EJ
    Medicine (Baltimore); 2018 Apr; 97(16):e0488. PubMed ID: 29668629
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
    Chudecka-Głaz A; Cymbaluk-Płoska A; Wężowska M; Menkiszak J
    PLoS One; 2018; 13(3):e0194270. PubMed ID: 29584739
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.
    Angell TE; Vyas CM; Barletta JA; Cibas ES; Cho NL; Doherty GM; Gawande AA; Howitt BE; Krane JF; Marqusee E; Strickland KC; Alexander EK; Moore FD; Nehs MA
    Ann Surg Oncol; 2018 May; 25(5):1410-1417. PubMed ID: 29520656
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Septal penetration correction in I-131 imaging following thyroid cancer treatment.
    Barrack F; Scuffham J; McQuaid S
    Phys Med Biol; 2018 Mar; 63(7):075012. PubMed ID: 29465414
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.
    Hofstra LS; Bos AM; de Vries EG; van der Zee AG; Willemsen AT; Rosing H; Beijnen JH; Mulder NH; Aalders JG; Willemse PH
    Gynecol Oncol; 2002 Jun; 85(3):517-23. PubMed ID: 12051884
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.